• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低聚半乳糖混合物(B-GOS)对老年人肠道微生物群、免疫参数和代谢组学的影响

Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons.

作者信息

Vulevic Jelena, Juric Aleksandra, Walton Gemma E, Claus Sandrine P, Tzortzis George, Toward Ruth E, Gibson Glenn R

机构信息

Clasado Research Services, Science and Technology Centre,Reading,UK.

Department of Food and Nutritional Sciences,The University of Reading,Reading,UK.

出版信息

Br J Nutr. 2015 Aug 28;114(4):586-95. doi: 10.1017/S0007114515001889. Epub 2015 Jul 28.

DOI:10.1017/S0007114515001889
PMID:26218845
Abstract

It is recognised that ageing induces various changes to the human colonic microbiota. Most relevant is a reduction in bifidobacteria, which is a health-positive genus. Prebiotics, such as galacto-oligosaccharides (GOS), are dietary ingredients that selectively fortify beneficial gut microbial groups. Therefore, they have the potential to reverse the age-related decline in bifidobacteria and modulate associated health parameters. We assessed the effect of GOS mixture (Bimuno (B-GOS)) on gut microbiota, markers of immune function and metabolites in forty elderly (age 65-80 years) volunteers in a randomised, double-blind, placebo (maltodextrin)-controlled, cross-over study. The intervention periods consisted of 10 weeks with daily doses of 5·5 g/d with a 4-week washout period in between. Blood and faecal samples were collected for the analyses of faecal bacterial populations and immune and metabolic biomarkers. B-GOS consumption led to significant increases in bacteroides and bifidobacteria, the latter correlating with increased lactic acid in faecal waters. Higher IL-10, IL-8, natural killer cell activity and C-reactive protein and lower IL-1β were also observed. Administration of B-GOS to elderly volunteers may be useful in positively affecting the microbiota and some markers of immune function associated with ageing.

摘要

人们认识到,衰老会引发人类结肠微生物群的各种变化。最相关的是双歧杆菌数量减少,双歧杆菌是一种对健康有益的菌属。益生元,如低聚半乳糖(GOS),是一类能选择性强化有益肠道微生物群的膳食成分。因此,它们有可能扭转与年龄相关的双歧杆菌数量下降趋势,并调节相关的健康参数。在一项随机、双盲、安慰剂(麦芽糊精)对照的交叉研究中,我们评估了低聚半乳糖混合物(Bimuno,B-GOS)对40名老年(65 - 80岁)志愿者肠道微生物群、免疫功能标志物和代谢物的影响。干预期为10周,每日剂量为5.5克/天,中间有4周的洗脱期。采集血液和粪便样本用于分析粪便细菌种群以及免疫和代谢生物标志物。摄入B-GOS导致拟杆菌和双歧杆菌显著增加,后者与粪便水中乳酸增加相关。还观察到白细胞介素-10、白细胞介素-8、自然杀伤细胞活性和C反应蛋白水平升高,白细胞介素-1β水平降低。对老年志愿者施用B-GOS可能有助于积极影响微生物群以及一些与衰老相关的免疫功能标志物。

相似文献

1
Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons.低聚半乳糖混合物(B-GOS)对老年人肠道微生物群、免疫参数和代谢组学的影响
Br J Nutr. 2015 Aug 28;114(4):586-95. doi: 10.1017/S0007114515001889. Epub 2015 Jul 28.
2
A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age.一项随机交叉研究调查了半乳糖寡糖对 50 岁以上男性和女性粪便微生物群的影响。
Br J Nutr. 2012 May;107(10):1466-75. doi: 10.1017/S0007114511004697. Epub 2011 Sep 13.
3
Fermentation properties and potential prebiotic activity of Bimuno® galacto-oligosaccharide (65 % galacto-oligosaccharide content) on in vitro gut microbiota parameters.Bimuno®低聚半乳糖(半乳糖低聚糖含量为65%)对体外肠道微生物群参数的发酵特性及潜在益生元活性
Br J Nutr. 2016 Aug;116(3):480-6. doi: 10.1017/S0007114516002269. Epub 2016 Jun 8.
4
Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress.在衰弱前期老年人和健康成年人中补充半乳糖寡糖增加了粪便双歧杆菌,但没有影响免疫功能和氧化应激。
Clin Nutr. 2021 May;40(5):3019-3031. doi: 10.1016/j.clnu.2020.12.034. Epub 2021 Jan 12.
5
Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment.探讨半乳糖寡糖对接受阿莫西林治疗的健康成年人肠道微生物群的影响。
Br J Nutr. 2014 Aug 28;112(4):536-46. doi: 10.1017/S0007114514001135. Epub 2014 Jun 13.
6
Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial.半乳糖寡糖可增加少女钙吸收和肠道双歧杆菌:一项双盲交叉试验。
Br J Nutr. 2013 Oct;110(7):1292-303. doi: 10.1017/S000711451300055X. Epub 2013 Mar 14.
7
A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults.摄入半乳糖寡糖混合物可降低代谢综合征标志物,并可调节超重成年人的粪便微生物群和免疫功能。
J Nutr. 2013 Mar;143(3):324-31. doi: 10.3945/jn.112.166132. Epub 2013 Jan 9.
8
Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study.单独的低聚木糖或与动物双歧杆菌乳酸亚种组成合生元组合,可诱导健康成年人的双歧杆菌生成并调节免疫功能标志物:一项双盲、安慰剂对照、随机、析因交叉研究。
Br J Nutr. 2014 Jun 14;111(11):1945-56. doi: 10.1017/S0007114513004261. Epub 2014 Mar 24.
9
Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers.新型低聚半乳糖混合物(B-GOS)对健康老年志愿者粪便微生物群谱和免疫功能的调节作用
Am J Clin Nutr. 2008 Nov;88(5):1438-46. doi: 10.3945/ajcn.2008.26242.
10
Supplementation with galacto-oligosaccharides increases the percentage of NK cells and reduces colitis severity in Smad3-deficient mice.补充半乳糖寡糖可增加 NK 细胞的百分比,并降低 Smad3 缺陷型小鼠结肠炎的严重程度。
J Nutr. 2012 Jul;142(7):1336-42. doi: 10.3945/jn.111.154732. Epub 2012 Apr 11.

引用本文的文献

1
The Impact of Low-Lactose, High Galacto-Oligosaccharides Milk on Gut Microbiome and Plasma Metabolome in Healthy Adults: A Randomized, Double-Blind, Controlled Clinical Trial Complemented by Ex Vivo Experiments.低乳糖、高半乳糖寡糖牛奶对健康成年人肠道微生物群和血浆代谢组的影响:一项由体外实验补充的随机、双盲、对照临床试验
Curr Dev Nutr. 2025 Jul 24;9(9):107506. doi: 10.1016/j.cdnut.2025.107506. eCollection 2025 Sep.
2
Galacto-Oligosaccharides Exert Bifidogenic Effects at Capsule-Compatible Ultra-Low Doses.低聚半乳糖在与胶囊相容的超低剂量下发挥双歧杆菌增殖作用。
Metabolites. 2025 Aug 5;15(8):530. doi: 10.3390/metabo15080530.
3
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease.
代谢功能障碍相关脂肪性肝病中肠道微生物群的作用机制及治疗进展
Gut Microbes. 2025 Dec;17(1):2500099. doi: 10.1080/19490976.2025.2500099. Epub 2025 May 20.
4
Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies-A Narrative Review.《分子精神病学的翻译:从生物标志物到个性化疗法——一篇叙述性综述》
Int J Mol Sci. 2025 May 1;26(9):4285. doi: 10.3390/ijms26094285.
5
Aging immunity: unraveling the complex nexus of diet, gut microbiome, and immune function.衰老免疫:解析饮食、肠道微生物群与免疫功能之间的复杂联系。
Immunometabolism (Cobham). 2025 May 9;7(2):e00061. doi: 10.1097/IN9.0000000000000061. eCollection 2025 Apr.
6
Factors affecting dysbiosis of the gut microbiota in the elderly and the progress of interventions in traditional Chinese and Western medicine.影响老年人肠道微生物群失调的因素及中西医干预进展
Front Cell Infect Microbiol. 2025 Mar 24;15:1529347. doi: 10.3389/fcimb.2025.1529347. eCollection 2025.
7
Association of the use of nonfood prebiotics, probiotics, and synbiotics with total and cause-specific mortality: a prospective cohort study.非食物益生元、益生菌和合生元的使用与全因死亡率及特定病因死亡率的关联:一项前瞻性队列研究。
Nutr J. 2025 Mar 20;24(1):45. doi: 10.1186/s12937-025-01104-w.
8
A review of mathematical modeling of bone remodeling from a systems biology perspective.从系统生物学角度对骨重塑数学建模的综述。
Front Syst Biol. 2024;4. doi: 10.3389/fsysb.2024.1368555. Epub 2024 Apr 8.
9
Prebiotics in food and dietary supplements: a roadmap to EU health claims.食品和膳食补充剂中的益生元:通往欧盟健康声称的路线图。
Gut Microbes. 2024 Jan-Dec;16(1):2428848. doi: 10.1080/19490976.2024.2428848. Epub 2024 Nov 15.
10
Probiotics and Prebiotics for the Treatment of Irritable Bowel Syndrome-A Narrative Review.用于治疗肠易激综合征的益生菌和益生元——一篇叙述性综述
J Clin Med. 2024 Oct 23;13(21):6337. doi: 10.3390/jcm13216337.